CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

DAILY EQUITY REPORT

7th November 2014

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

INDIAN FACE

INDIAN MARKET
INDICES

CLOSE

PREVIOUS

SENSEX

27,915.88

27,860.38

NIFTY

8,338.30

8,324.15

INDIAN EQUITY BENCHMARK ended at record closing highs

and the Sensex topped 28,000 mark intra-days for the first

ASIAN MARKET

time as foreign institutional investors remained aggressive

INDICES

CLOSE

PREVIOUS

buyers in equities. Slew of economic reforms recently

NIKKEI

16,937.32

16,862.47

announced by the government along with decline in global

HANG SENG

23,695.62

23,845.66

KOSPI

1,931.43

1,935.19

SECTORIAL INDICES

crude oil prices aided the buying interest of the investors.

Further, The HSBC Purchasing Managers' Index (PMI),

compiled by Market, fell to 50 in October from September's

INDICES

CLOSE

CHANGE (%)

CNX 100

8,276.00

0.12

S&P CNX 500

6,716.25

0.18

CNX MIDCAP

11,975.60

0.14

CNX 200

4,251.55

0.15

BANK NIFTY

17,371.60

1.39

TOP GAINERS

51.6, the lowest in six months and right on the break-even

point between growth and contraction.

Wockhardt lost 2.36% after consolidated net profit fell 98%

to Rs3 crore on 14% decline in sales to Rs1029 crore in Q2
September 2014 over Q2 September 2013.

GLOBAL FACE

SCRIPT

CLOSE

CHANGE (%)

AXIS BANK

460.55

3.44

HCL TECH

1,608.75

2.42

prices dragged down U.S. shares, while the dollar took a

DR REDDY

3,258.00

2.41

breather after this week's rally.

BPCL

741.10

2.35

TOP LOSERS

Asian shares got off to a lackluster start after a plunge in oil

European shares rose early on Wednesday, reversing most of

the previous session's losses, as a raft of positive results from

SCRIPT

CLOSE

CHANGE (%)

JINDALSTEL

161.35

-5.17

CAIRN

276.70

-4.85

HINDALCO

156.20

-4.49

SSLT

251.75

-4.00

companies helped lift sentiment.

US stock index futures poised for a higher opening at the Wall

Street on Wednesday.

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

MARKET MOVERS UPSIDE

NIFTY SPOT

TCS

2599.50

CHANGE
(%)
0.35

ITC

359.15

1.04

S3

S2

S1

0.95

8258

8300

8319

SCRIPT

INFOSYS
HDFC BANK

CLOSE

4124.80
912.80

0.23

TREND

STRATEGY

BULLISH

BUY ON DIPS
PIVOT POINTS
P
R1

8342

8361

SUPPORT
S1-8320
S2-8290

NIFTY

R2

R3

8384

8426

RESISTANCE
R1-8370
R2-8430

MARKET MOVERS DOWNSIDE

SCRIPT

CLOSE

ONGC

403.60

CHANGE
(%)
[0.23]

RELIANCE

991.30

[1.1]

COAL INDIA

349.10

[2.81]

HDFC

1100.55

[1.78]

FII & DII ACTIVITY

INSTITUTION

NET BUY
(CR.)

NET SELL
(CR)

FII

4459.07

3045.73

DII

1334.20

2517.28

BANK NIFTY FUTURE

TREND
BULLISH
PIVOT POINTS
S3

NSE TOTALS
INDICES

ADVANCES

DECLINES

NIFTY

23

27

BANK NIFTY

STRATEGY
BUY ON DIPS

16760

S2

S1

R1

17086

17279

17412

17605

BANK NIFTY

SUPPORT
S1-17300
S2-17150

R2

R3

17737

18063

RESISTANCE
R1-17550
R2-17750

CAPITALSTARS FINANCIAL RESEARCH PVT. LTD.

Daily Equity Report

r

MARKET TALKS

Mumbai based Loop Mobile, for about Rs 700 crore, Report stated

India HSBC Oct Services PMI at 6month

that the approval for the transaction was awaited from the relevant
authorities as a result of which Bharti Airtel has withdrawn from the
proposed transaction causing huge loss to the company.

The HSBC Purchasing Managers' Index fell to 50 in October from

September's 51.6, the lowest in six months and right on the breakeven point between growth and contraction. New business growth

slowed a five-month low but continued to expand at a modest pace.

Ranbaxy gets USFDA nod for

Fenofibrate Capsules...stock up 3%

Growth in India's dominant service industry stalled last month as

Ranbaxy has received approval from the U.S. FDA to manufacture

new orders came in at a weaker pace,

and market Fenofibrate Capsules USP, 43 mg and 130 mg. The

Office of Generic Drugs, U.S. FDA, has determined the Ranbaxy

Hexaware Technologies Q3 cons net

profit at Rs86 crores

formulations to be bioequivalent and have the same therapeutic

effect as that of the reference listed drug Antara(R) Capsules, 43
and 130 mg, respectively, of Lupin Atlantis (Lupin).

Hexaware Technologies Ltd has posted a net profit of Rs. 860.202

Mn for the quarter ended September 30, 2014 whereas the same
was at Rs. 987.236 mn for the quarter ended September 30, 2013.
Total Income is Rs. 6737.170 million for the quarter ended

GlaxoSmithKline Consumer Q2 net

profit at Rs1602.90 mn

September 30, 2014 whereas the same was at Rs. 6278.286 million
for the quarter ended September 30, 2013.

GlaxoSmithKline Consumer Healthcare Ltd has posted a net profit

of Rs. 1602.90 mn for the quarter ended Sept 30, 2014 whereas the

Bharti Airtel calls off deal to buy

Loop

same was at net profit of Rs. 1469.30 mn for the quarter ended Sep
30, 2013.Total Income is Rs. 11754.60 mn for the quarter ended
Sep 30, 2014 whereas the same was at Rs. 10574.70 million for the

Bharti Airtel has called off deal to acquire business and assets of

quarter ended Sep 30, 2013..

DISCLAIMER
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Use of this report in no way constitutes a client/advisor relationship, all information we communicate to you (the subscriber) either through
our Web site or other forms of communications, are purely for informational purposes only. We recommend seeking individual investment
advice before making any investment, for you are assuming sole liability for your investments. Capital Stars will in no way have discretionary
authority over your trading or investment accounts.
All rights reserved.